A phase 2 single-arm study to assess clinical activity, efficacy and safety of enzalutamide (ENZA) with trastuzumab in HER2+ AR+ metastatic or locally advanced breast cancer.
2015 ◽
Vol 33
(15_suppl)
◽
pp. TPS640-TPS640
2013 ◽
2013 ◽